Ryo Saito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ryo Saito has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Atsu Aiba
Laboratory of Animal Resources, Center for Disease Biology and Integrated Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan
1 shared publication - Qingrui Liu
Department of Cellular Neurobiology, Graduate School of Medicine, The University of Tokyo
1 shared publication - Shigeo Okabe
Department of Cellular Neurobiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan
1 shared publication - Takanobu Nakazawa
Laboratory of Molecular Biology, Department of Bioscience, Graduate School of Life Sciences, Tokyo University of Agriculture, Tokyo, Japan
1 shared publication - Yasuhiro Go
Graduate School of Information Science, University of Hyogo, Kobe 650-0047, Japan
1 shared publication - Yutaro Kashiwagi
Department of Cellular Neurobiology, Graduate School of Medicine, The University of Tokyo
1 shared publication
Latest Publications
- Open Access
- 11 August 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Spine nanostructure profiling of cultured neurons from mouse models reveals a schizophrenia-linked role for Ecrg4
Dendritic spine dysfunction may contribute to the etiology and symptom expression of neuropsychiatric disorders. The intimate relationship between spine morphology and function suggests that decoding disease-related abnormalities from spine morphology can aid in developing synapse-targeted interventions. Here, we describe a population analysis of dendritic spine nanostructure applied to the objective grouping of multiple mouse models of neuropsychiatric disorders. This method has identified two major groups of spine phenotypes linked to schizophrenia and autism spectrum disorder (ASD). An increase in spine subpopulation with small volumes characterized the spines of schizophrenia-associated mouse models, whereas a spine subset with large volumes increased in ASD models. Schizophrenia-associated mouse models showed higher similarity in spine morphology, driven by reduced size and growth of nascent spines. The expression of Ecrg4 , a gene encoding small secretory peptides, was increased in schizophrenia-associated mouse models, and functional studies confirmed its critical involvement in impaired spine dynamics and shape. These results suggest that population-level spine analysis provides rich insights into heterogeneous spine pathology, facilitating the identification of new molecular targets related to core synaptic dysfunction.
- 11 August 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Open AccessSpine nanostructure profiling of cultured neurons from mouse models reveals a schizophrenia-linked role for Ecrg4
Dendritic spine dysfunction may contribute to the etiology and symptom expression of neuropsychiatric disorders. The intimate relationship between spine morphology and function suggests that decoding disease-related abnormalities from spine morphology can aid in developing synapse-targeted interventions. Here, we describe a population analysis of dendritic spine nanostructure applied to the objective grouping of multiple mouse models of neuropsychiatric disorders. This method has identified two major groups of spine phenotypes linked to schizophrenia and autism spectrum disorder (ASD). An increase in spine subpopulation with small volumes characterized the spines of schizophrenia-associated mouse models, whereas a spine subset with large volumes increased in ASD models. Schizophrenia-associated mouse models showed higher similarity in spine morphology, driven by reduced size and growth of nascent spines. The expression of Ecrg4 , a gene encoding small secretory peptides, was increased in schizophrenia-associated mouse models, and functional studies confirmed its critical involvement in impaired spine dynamics and shape. These results suggest that population-level spine analysis provides rich insights into heterogeneous spine pathology, facilitating the identification of new molecular targets related to core synaptic dysfunction.